A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs

[Image: see text] Chemotherapy is almost exclusively administered via the intravenous (IV) route, which has serious limitations (e.g., patient discomfort, long hospital stays, need for trained staff, high cost, catheter failures, infections). Therefore, the development of effective and less costly c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordat, Alexandre, Boissenot, Tanguy, Ibrahim, Nada, Ferrere, Marianne, Levêque, Manon, Potiron, Léa, Denis, Stéphanie, Garcia-Argote, Sébastien, Carvalho, Olivia, Abadie, Jérôme, Cailleau, Catherine, Pieters, Grégory, Tsapis, Nicolas, Nicolas, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585574/
https://www.ncbi.nlm.nih.gov/pubmed/36193551
http://dx.doi.org/10.1021/jacs.2c04944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585574/
https://www.ncbi.nlm.nih.gov/pubmed/36193551
http://dx.doi.org/10.1021/jacs.2c04944

Ejemplares similares